Showing results (31-40 of 181) with videos related to

Sort By:
Pageof 19
Ochsner Journal|May 24, 2011
Effective glycemic management in hospitalized patients: a multidisciplinary approachMargaret Bolton, Anita Richard, Lawrence Blonde, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 6, 2014
Fixed-dose combination therapy in type 2 diabetes mellitusLawrence Blonde, Zinnia T San Juan, Peggy Bolton
Evolution; International Journal of Organic Evolution|May 12, 2007
Testing the role of interspecific competition in the evolutionary origin of elevational zonation: an example with Buarremon brush-finches (Aves, Emberizidae) in the neotropical mountainsCarlos Daniel Cadena
Diabetes, Obesity & Metabolism|April 21, 2021
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programmeLawrence Blonde, Timothy Bailey, Sean D Sullivan, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|March 3, 2020
Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and ConsequencesSusan L Karam, Jared Dendy, Shruti Polu, et al.
Postgraduate Medicine|June 12, 2014
Influence of baseline glycemia on outcomes with insulin glargine use in patients uncontrolled on oral agentsMary Ann Banerji, Michelle A Baron, Ling Gao, et al.
Clinical Drug Investigation|February 20, 2016
Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given AloneTina Vilsbøll, Jiten Vora, Henrik Jarlov, et al.
Diabetes, Obesity & Metabolism|March 15, 2018
Long-term sustainability of glycaemic achievements with second-line antidiabetic therapies in patients with type 2 diabetes: A real-world studyOlga Montvida, Jonathan E Shaw, Lawrence Blonde, et al.
Current Medical Research and Opinion|October 30, 2018
Rationale for a titratable fixed-ratio co-formulation of a basal insulin analog and a glucagon-like peptide 1 receptor agonist in patients with type 2 diabetesLawrence Blonde, John E Anderson, Pavan Chava, et al.
Journal of the American Academy of Nurse Practitioners|October 27, 2006
Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education ProgramLawrence Blonde, Judith Dempster, Joanne M Gallivan, et al.
Pageof 19